Schedule 13G ownership disclosure

Evolus Inc

Common stock, par value $0.00001 per share · CUSIP: 30052C107

Event date: 2024-12-31

Filing-level shares
2,136,449.00
Percent of class
3.4%
  • Medytox Inc.

    Shares: 2,136,449.00 · Class: 3.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001839882-25-007658
Form type
SCHEDULE 13G/A
Filer
Evolus, Inc.
CIK
CIK 1570562
Filed
Feb 06, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub